🇺🇸 FDA
Pipeline program

Teverelix TFA

Phase 2 small_molecule active

Quick answer

Teverelix TFA for Advanced prostate cancer is a Phase 2 program (small_molecule) at Nordic Bioscience A/S with 1 ClinicalTrials.gov record(s).

Program details

Company
Nordic Bioscience A/S
Indication
Advanced prostate cancer
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials